SPAG5 and urinary bladder carcinoma: These nanoparticles can efficiently avoid endosome degradation and deliver the therapeutic siRNA into the cytoplasm rapidly, resulting in significantly inhibited expression of SPAG5 expression and reduced bladder cancer progression and growth.